ABSOLOGY

본문 바로가기

팝업레이어 알림

팝업레이어 알림이 없습니다.
ABSOL VET Contact Us Login
Language
  • · Korean
  • · English
Diagnostic System
Diagnostic System
News

Thank you, ASVCD Congress 2024!

A big thank you to everyone who stopped by the Absology booth on June 04~05 2024. We …

Successful FIME 2024 in Miami Beach!

We at Absology want to thank everyone who visited our booth and engaged with our team…

Police Security Expo 2024 : Absology & Public Safe…

June 2024 witnessed a breakthrough for Absology Co., Ltd. at the Police Security Expo…

Global Vision, Local Impact: Municipal Clinics pro…

We are delighted to announce our strategic partnership with the Clinical Municipales …

'ABSOLOGY' has successfully attracted an investmen…

Absology Co., Ltd., an in vitro immunodiagnostic medical device company, com…

[2023.05] Absology signs listing sponsorship agree…

[Summary] Absolology's three main product lines are ABSOL, a susceptible in vitr…

[2023.02] Absology signs export contract for 50 bi…

 [Summery] Absology (CEO Han Sang Jo) recently participated in 'MedLab', th…

[2022.12] Interview : Abosology CEO of Cho Han-san…

 [Summary] Based on the mission of 'a company that goes beyond diagnosis to…

[2022.11] Absology draws attention from in vitro d…

 [Summery] It is reported that Absolology Co., Ltd. (CEO Jo Han Sang) has w…

[2022.05] In vitro immunodiagnostic venture compan…

 [Summery] Absology has begun preparing for listing with the goal of IPO in…

[2022.04] Absology Selected as the Host Organizati…

 [Summery] As a result, Absolology has been able to cooperate with People Bio Co…

[2022.01] Absology is in the spotlight for in vitr…

 [Summary] Absol, a high-sensitivity in vitro immunodiagnostic device developed …

[2021.11] Absology-SG Medical Global Market Entry …

 [Summery] Absolology Co., Ltd., a bio-medical device company, recently signed a…

[2021.08] Absology Approves Myocardial Infarction …

 [Summery] This product has been proven to have the same performance with …

[2021.07] Absolology Licenses Export of Corona Neu…

 [Summery] Abthology explained, "As a result of clinical trials at Kangwon …

[2021.06] Absolology innovates medical devices wit…

[Summery]  he first target is tau protein, which is known to influence the dev…

[2021.01] MOU for the development of PEOPLEBIO-Abs…

 [Summery]  The first target is tau protein, which is known to influence th…

[2019.11] IntekBio has two key technologies trans…

[Summery] ABSOL have two technologies that FIA(Fluorescent Immunoassay) and on-off&nb…

[2019.05] Intek Plus completes in vitro diagnostic…

 [Summery] ABSOLOGY of in-vitro diagnostic kits have recently been attracting at…

Certificate of ISO 13485

 Absology Co., Ltd. (= Intekbio) has acquired the certificate of ISO 13485,…

Certificate of GMP

Absology Co., Ltd. (Intekbio) has acquired the certificate of GMP, March 2019. 

News

Thank you, ASVCD Congress 2024!

A big thank you to everyone who stopped by the Absology booth on June 04~05 2024. We …

Successful FIME 2024 in Miami Beach!

We at Absology want to thank everyone who visited our booth and engaged with our team…

Police Security Expo 2024 : Absology & Public Safe…

June 2024 witnessed a breakthrough for Absology Co., Ltd. at the Police Security Expo…

Global Vision, Local Impact: Municipal Clinics pro…

We are delighted to announce our strategic partnership with the Clinical Municipales …

'ABSOLOGY' has successfully attracted an investmen…

Absology Co., Ltd., an in vitro immunodiagnostic medical device company, com…

[2023.05] Absology signs listing sponsorship agree…

[Summary] Absolology's three main product lines are ABSOL, a susceptible in vitr…

[2023.02] Absology signs export contract for 50 bi…

 [Summery] Absology (CEO Han Sang Jo) recently participated in 'MedLab', th…

[2022.12] Interview : Abosology CEO of Cho Han-san…

 [Summary] Based on the mission of 'a company that goes beyond diagnosis to…

[2022.11] Absology draws attention from in vitro d…

 [Summery] It is reported that Absolology Co., Ltd. (CEO Jo Han Sang) has w…

[2022.05] In vitro immunodiagnostic venture compan…

 [Summery] Absology has begun preparing for listing with the goal of IPO in…

[2022.04] Absology Selected as the Host Organizati…

 [Summery] As a result, Absolology has been able to cooperate with People Bio Co…

[2022.01] Absology is in the spotlight for in vitr…

 [Summary] Absol, a high-sensitivity in vitro immunodiagnostic device developed …

[2021.11] Absology-SG Medical Global Market Entry …

 [Summery] Absolology Co., Ltd., a bio-medical device company, recently signed a…

[2021.08] Absology Approves Myocardial Infarction …

 [Summery] This product has been proven to have the same performance with …

[2021.07] Absolology Licenses Export of Corona Neu…

 [Summery] Abthology explained, "As a result of clinical trials at Kangwon …

[2021.06] Absolology innovates medical devices wit…

[Summery]  he first target is tau protein, which is known to influence the dev…

[2021.01] MOU for the development of PEOPLEBIO-Abs…

 [Summery]  The first target is tau protein, which is known to influence th…

[2019.11] IntekBio has two key technologies trans…

[Summery] ABSOL have two technologies that FIA(Fluorescent Immunoassay) and on-off&nb…

[2019.05] Intek Plus completes in vitro diagnostic…

 [Summery] ABSOLOGY of in-vitro diagnostic kits have recently been attracting at…

Certificate of ISO 13485

 Absology Co., Ltd. (= Intekbio) has acquired the certificate of ISO 13485,…

Certificate of GMP

Absology Co., Ltd. (Intekbio) has acquired the certificate of GMP, March 2019.